MedWire News: UK researchers have found that early recurrent ischemic stroke (ERIS) after the use of intravenous recombinant tissue-type plasminogen activator (iv rtPA) may be more common than previously thought.
MedWire News: UK researchers have found that early recurrent ischemic stroke (ERIS) after the use of intravenous recombinant tissue-type plasminogen activator (iv rtPA) may be more common than previously thought.